SCHEMBL17526735

SCHEMBL17526735

CC[C@H](CCO)CCCN1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.42
CHRM5 P08912 2/20 0.39
CHRM3 P20309 2/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
SIGMAR1 Q99720 3/20 0.37
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GNAO1 P09471 4/20 0.35
GNAI3 P08754 3/20 0.35
GNAI1 P63096 3/20 0.35
ALDH1A1 P00352 2/20 0.34
GBA1 P04062 1/20 0.34
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526641 1.00 CXCR4 (0.42) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526859 0.95 CXCR4 (0.43) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526517 0.95 CXCR4 (0.43) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526742 0.93 CXCR4 (0.46) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526820 0.93 CXCR4 (0.46) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526564 0.90 CXCR4 (0.40) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526835 0.90 CXCR4 (0.40) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL21348729 0.88 CXCR4 (0.43) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17526941 0.85 CXCR4 (0.41) CXCR4CHRM5CHRM3CHRM2CHRM4
SCHEMBL17523836 0.84 CHRM5 (0.38) CXCR4CHRM5CHRM3CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 CXCR4 2243/4885CHRM5 4341/4885CHRM3 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.